Bromocriptine treatment in Parkinson's disease.

Thirty-one patients with Parkinson's disease were treated with the ergot alkaloid bromocriptine, a drug which stimulates dopamine receptors. Bromocriptine had a slight therapeutic effect in patients on no other treatment and an additional effect in patients on levodopa. The mean optimum dosage of br...

Celý popis

Podrobná bibliografie

Vydáno v:	J Neurol Neurosurg Psychiatry
Hlavní autoři:	Parkes, J D, Marsden, C D, Donaldson, I, Galea-Debono, A, Walters, J, Kennedy, G, Asselman, P
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMJ Publishing Group 1976
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC492245/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/772175/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.39.2.184
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!